Indian drug maker Intas Pharmaceuticals, which is backed by the Abu Dhabi Investment Authority (ADIA) and homegrown private equity giant ChrysCapital, is in advanced talks to acquire a stake in Globion, a manufacturer of poultry vaccines and veterinary medicines, DealStreetAsia has learnt.